CHUGAI PHARMACEUTICAL CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,985 JPY | -2.14% |
|
-1.29% | -6.68% |
| May. 01 | Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation | MT |
| Apr. 25 | Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5% | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1,090B 7.06B | Sales 2025 * | 1,134B 7.34B | Capitalization | 8,381B 54.26B |
|---|---|---|---|---|---|
| Net income 2024 * | 345B 2.23B | Net income 2025 * | 368B 2.38B | EV / Sales 2024 * | 6.88 x |
| Net cash position 2024 * | 881B 5.7B | Net cash position 2025 * | 1,003B 6.49B | EV / Sales 2025 * | 6.51 x |
| P/E ratio 2024 * |
24.3
x | P/E ratio 2025 * |
22.8
x | Employees | 7,604 |
| Yield 2024 * |
1.66% | Yield 2025 * |
1.75% | Free-Float | 38.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
| 1 day | -2.14% | ||
| 1 week | -1.29% | ||
| Current month | -1.29% | ||
| 1 month | -7.60% | ||
| 3 months | -4.01% | ||
| 6 months | +7.16% | ||
| Current year | -6.68% |
1 week
4 943.00
5 159.00
1 month
4 726.005 482.00
Current year
4 726.006 697.00
1 year
3 522.006 697.00
3 years
3 191.006 697.00
5 years
2 290.006 697.00
10 years
867.676 697.00
| Managers | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 87-03-31 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 15-02-28 |
Motoo Ueno
BRD | Director/Board Member | 66 | 84-03-31 |
James H. Sabry
BRD | Director/Board Member | 65 | 19-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 15 M€ | +10.45% | ||
| 1.87% | 60 M€ | +16.78% | ||
| 1.59% | 4 M€ | +17.08% | ||
| 1.53% | 67,864 M€ | +16.85% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-07 | 4,985 | -2.14% | 2 536 200 |
| 24-05-02 | 5,094 | +1.35% | 2,013,600 |
| 24-05-01 | 5,026 | -0.48% | 1,680,000 |
Delayed Quote Japan Exchange, May 07, 2024 at 02:00 am EDT
More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
5,094
JPY
Average target price
6,093
JPY
Spread / Average Target
+19.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.68% | 54.43B | |
| +31.52% | 690B | |
| +25.10% | 546B | |
| -5.21% | 358B | |
| +17.02% | 323B | |
| +5.01% | 287B | |
| +14.06% | 235B | |
| +5.27% | 199B | |
| -9.98% | 195B | |
| +3.98% | 161B |
- Stock Market
- Equities
- 4519 Stock